Additional Proxy Soliciting Materials (definitive) (defa14a)
2022年5月2日 - 9:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
|
|
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material under §240.14a-12 |
Ortho Clinical Diagnostics Holdings plc
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
|
|
☒ |
No fee required. |
☐ |
Fee paid previously with preliminary materials |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Ortho Clinical Diagnostics (NASDAQ:OCDX)
過去 株価チャート
から 12 2024 まで 1 2025
Ortho Clinical Diagnostics (NASDAQ:OCDX)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about Ortho Clinical Diagnostics Holdings PLC (ナスダック市場): 0 recent articles
その他のOrtho Clinical Diagnostics Holdings Plcニュース記事